CDAN3
MCID: ANM037
MIFTS: 31

Anemia, Congenital Dyserythropoietic, Type Iii (CDAN3)

Categories: Rare diseases, Blood diseases, Genetic diseases, Metabolic diseases, Immune diseases

Aliases & Classifications for Anemia, Congenital Dyserythropoietic, Type Iii

MalaCards integrated aliases for Anemia, Congenital Dyserythropoietic, Type Iii:

Name: Anemia, Congenital Dyserythropoietic, Type Iii 57
Congenital Dyserythropoietic Anemia, Type Iii 29 13 73
Cda Iii 57 53 59
Dyserythropoietic Anemia, Congenital Type 3 76 53
Congenital Dyserythropoietic Anemia Type 3 53 59
Dyserythropoietic Anemia, Congenital, Type Iii 57
Congenital Dyserythropoietic Anemia Type Iii 59
Anemia with Multinucleated Erythroblasts 57
Erythroreticulosis, Hereditary Benign 57
Cda Type Iii 59
Cda Type 3 59
Cdan3 57

Characteristics:

Orphanet epidemiological data:

59
congenital dyserythropoietic anemia type iii
Inheritance: Autosomal dominant,Autosomal recessive; Prevalence: <1/1000000 (Worldwide); Age of onset: All ages; Age of death: normal life expectancy;

OMIM:

57
Inheritance:
autosomal dominant
also two recessive forms


HPO:

32
anemia, congenital dyserythropoietic, type iii:
Inheritance autosomal dominant inheritance


Classifications:



Summaries for Anemia, Congenital Dyserythropoietic, Type Iii

NIH Rare Diseases : 53 The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs.Orpha Number: 98870Disease definitionCongenital dyserythropoietic anemia type III (CDA III) is a rare form of CDA (see this term) characterized by dyserythropoiesis, with big multinucleated erythroblasts in the bone marrow, and manifesting with mild to moderate anemia.EpidemiologyThe prevalence is unknown. Three families have been reported with autosomal dominant CDA III in Sweden, America and Argentina. Other sporadic CDA III-like cases have been described. In total, about 60 cases have been reported worldwide.Clinical descriptionThe clinical presentation is variable. CDA III can manifest with mild anemia and jaundice in neonates but it may not be discovered until childhood or adulthood. Intensity of symptoms increases during infections, following trauma, and during pregnancy. It can also be associated with monoclonal gammopathies, multiple myeloma (see this term) and retinal angioid streaks,which can lead to visual impairment. Sporadic cases of CDA III have been associated with severe erythroid hyperplasia, skeletal disorders, intellectual deficit, and hepatosplenomegaly.EtiologyRecently, the KIF23 gene (15q23) has been identified as the causal mutation for AD CDA III. This gene encodes mitotic kinesin-like protein 1 (MKLP1) which is crucial for cytokinesis.Diagnostic methodsDiagnosis is based on laboratory findings. The disorder is characterized by mild anemia, macrocytosis in the peripheral blood, and giant multinucleated erythroblasts (containing up to 12 nuclei) in the bone marrow. Increased levels of serum thymidine kinase, lactate dehydrogenase and bilirubin and very low or undetectable haptoglobin are also characteristic of this disease. Mutations in the KIF23 gene can also determine a diagnosis of CDA III.Differential diagnosisThe diagnosis of CDA III should be considered following exclusion of other causes of macrocytosis (B12 deficiency, folic acid deficiency or other megaloblastic anemias such as pernicious anemia or thiamine-responsive megaloblastic anemia syndrome; see these terms), acquired dyserythropoiesis (myelodysplastic syndrome, acute erythroid leukemia), hemolytic anemias (hereditary spherocytosis) or microcytic anemias (thalassemias and iron deficiency anemias). Gilbert syndrome (see these terms) and infections should be also excluded.Antenatal diagnosisPrenatal diagnosis for at-risk pregnancies requires prior identification of the disease-causing mutations in the family.Genetic counselingGenetic counseling is possible in CDA III. It is inherited in an autosomal dominant mode. Other sporadic CDA III-like cases have been reported with an autosomal recessive pattern of inheritance, suggesting a different genetic alteration than KIF23 associated CDA III and possibly another subtype of CDA.Management and treatmentIn most cases anemia is mild and treatment is not necessary. Only during times of extreme anemia (often due to pregnancy or surgery), may a transfusion be needed. Ophthalmological follow-up is recommended in those with eye manifestations.PrognosisIn most cases the prognosis is good and there is no decrease in life expectancy. Quality of life may be affected in those with visual impairment.Visit the Orphanet disease page for more resources.

MalaCards based summary : Anemia, Congenital Dyserythropoietic, Type Iii, also known as congenital dyserythropoietic anemia, type iii, is related to congenital dyserythropoietic anemia. An important gene associated with Anemia, Congenital Dyserythropoietic, Type Iii is KIF23 (Kinesin Family Member 23). Affiliated tissues include bone marrow, bone and eye, and related phenotypes are anemia and poikilocytosis

OMIM : 57 Congenital dyserythropoietic anemia type III is a rare disorder characterized by nonprogressive mild to moderate hemolytic anemia, macrocytosis in the peripheral blood, and giant multinucleated erythroblasts in the bone marrow (Lind et al., 1995). For a discussion of genetic heterogeneity of congenital dyserythropoietic anemia, see 224120. (105600)

Wikipedia : 76 Congenital dyserythropoietic anemia type III (CDA III) is a rare autosomal dominant disorder... more...

Related Diseases for Anemia, Congenital Dyserythropoietic, Type Iii

Diseases in the Congenital Dyserythropoietic Anemia family:

Anemia, Congenital Dyserythropoietic, Type Iii Anemia, Congenital Dyserythropoietic, Type Ii
Anemia, Congenital Dyserythropoietic, Type Ia Anemia, Congenital Dyserythropoietic, Type Iv
Anemia, Congenital Dyserythropoietic, Type Ib

Diseases related to Anemia, Congenital Dyserythropoietic, Type Iii via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 congenital dyserythropoietic anemia 9.9

Symptoms & Phenotypes for Anemia, Congenital Dyserythropoietic, Type Iii

Symptoms via clinical synopsis from OMIM:

57
Skin:
jaundice

Misc:
increased frequency of myeloma or monoclonal gammopathy

Heme:
congenital dyserythropoietic anemia
macrocytosis
giant bone marrow multinuclear erythroblasts

Lab:
hemosiderinuria
grossly disorganized erythroblast nuclei
intraerythroblastic inclusions
highly polyploid giant mononucleate erythroblasts
elevated levels of serum thymidine kinase


Clinical features from OMIM:

105600

Human phenotypes related to Anemia, Congenital Dyserythropoietic, Type Iii:

59 32 (show all 24)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 anemia 59 32 hallmark (90%) Very frequent (99-80%) HP:0001903
2 poikilocytosis 59 32 hallmark (90%) Very frequent (99-80%) HP:0004447
3 anisocytosis 59 32 hallmark (90%) Very frequent (99-80%) HP:0011273
4 hyperbilirubinemia 59 32 frequent (33%) Frequent (79-30%) HP:0002904
5 increased serum iron 59 32 frequent (33%) Frequent (79-30%) HP:0003452
6 increased mean corpuscular volume 59 32 frequent (33%) Frequent (79-30%) HP:0005518
7 fatigue 59 32 frequent (33%) Frequent (79-30%) HP:0012378
8 abnormal proerythroblast morphology 59 32 frequent (33%) Frequent (79-30%) HP:0025035
9 increased total iron binding capacity 59 32 frequent (33%) Frequent (79-30%) HP:0025196
10 abnormal cellular phenotype 59 32 frequent (33%) Frequent (79-30%) HP:0025354
11 gingival bleeding 59 32 occasional (7.5%) Occasional (29-5%) HP:0000225
12 pallor 59 32 occasional (7.5%) Occasional (29-5%) HP:0000980
13 melena 59 32 occasional (7.5%) Occasional (29-5%) HP:0002249
14 headache 59 32 occasional (7.5%) Occasional (29-5%) HP:0002315
15 elevated hepatic transaminases 59 32 occasional (7.5%) Occasional (29-5%) HP:0002910
16 post-partum hemorrhage 59 32 occasional (7.5%) Occasional (29-5%) HP:0011891
17 oral cavity bleeding 59 32 occasional (7.5%) Occasional (29-5%) HP:0030140
18 short stature 59 32 very rare (1%) Very rare (<4-1%) HP:0004322
19 abnormality of erythrocytes 59 Occasional (29-5%)
20 abnormality of cells of the erythroid lineage 59 Frequent (79-30%)
21 jaundice 32 HP:0000952
22 macrocytic anemia 32 HP:0001972
23 congenital hypoplastic anemia 32 HP:0004810
24 hemosiderinuria 32 HP:0012543

Drugs & Therapeutics for Anemia, Congenital Dyserythropoietic, Type Iii

Search Clinical Trials , NIH Clinical Center for Anemia, Congenital Dyserythropoietic, Type Iii

Genetic Tests for Anemia, Congenital Dyserythropoietic, Type Iii

Genetic tests related to Anemia, Congenital Dyserythropoietic, Type Iii:

# Genetic test Affiliating Genes
1 Congenital Dyserythropoietic Anemia, Type Iii 29

Anatomical Context for Anemia, Congenital Dyserythropoietic, Type Iii

MalaCards organs/tissues related to Anemia, Congenital Dyserythropoietic, Type Iii:

41
Bone Marrow, Bone, Eye

Publications for Anemia, Congenital Dyserythropoietic, Type Iii

Articles related to Anemia, Congenital Dyserythropoietic, Type Iii:

# Title Authors Year
1
Antiphospholipid syndrome in a patient suffering from congenital dyserythropoietic anemia type III. ( 25900788 )
2015
2
Congenital dyserythropoietic anemia type III (CDA III) is caused by a mutation in kinesin family member, KIF23. ( 23570799 )
2013
3
New sporadic case of congenital dyserythropoietic anemia type III in an aged woman: detailed description of ultrastructural findings. ( 11994986 )
2002
4
Congenital dyserythropoietic anemia type III associated with congenital atrioseptal defect has led to severe cardiac problems in a 32-year-old patient. ( 10911387 )
2000
5
Congenital dyserythropoietic anemia type III. ( 10897128 )
2000
6
Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21-q25. ( 7711721 )
1995
7
Congenital dyserythropoietic anemia type III with unbalanced globin chain synthesis. ( 8005239 )
1994
8
Long-term cinemicrography of erythroblasts from a patient with congenital dyserythropoietic anemia type III: direct observation of dysplastic erythroblast formation. ( 8312576 )
1993
9
Precipitation of beta-globin chains within the erythropoietic cells of a patient with congenital dyserythropoietic anemia, type III. ( 3828237 )
1987
10
Congenital dyserythropoietic anemia type III. studies on erythroid differentiation of blood erythroid progenitor cells (BFUE) in vitro. ( 7202587 )
1980

Variations for Anemia, Congenital Dyserythropoietic, Type Iii

Expression for Anemia, Congenital Dyserythropoietic, Type Iii

Search GEO for disease gene expression data for Anemia, Congenital Dyserythropoietic, Type Iii.

Pathways for Anemia, Congenital Dyserythropoietic, Type Iii

GO Terms for Anemia, Congenital Dyserythropoietic, Type Iii

Sources for Anemia, Congenital Dyserythropoietic, Type Iii

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....